Total Valuation
Linike Medical Group has a market cap or net worth of $3.67M. The enterprise value is $23.32M.
Market Cap$3.67M
Enterprise Value$23.32M
Share Statistics
Linike Medical Group has 668,948,060 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding668,948,060
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Linike Medical Group’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 5.57%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)5.57%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee10.00T>
Profits Per Employee10.00T>
Employee Count―
Asset Turnover0.19
Inventory Turnover0.01
Valuation Ratios
The current PE Ratio of Linike Medical Group is 3.9. Linike Medical Group’s PEG ratio is -0.00386.
PE Ratio3.9
PS Ratio1.39
PB Ratio0.39
Price to Fair Value0.39
Price to FCF-56.53
Price to Operating Cash Flow-2.47
PEG Ratio-0.00386
Income Statement
In the last 12 months, Linike Medical Group had revenue of 10.68M and earned 3.09M in profits. Earnings per share was <0.01.
Revenue10.68M
Gross Profit10.54M
Operating Income3.09M
Pretax Income3.09M
Net Income3.09M
EBITDA3.22M
Earnings Per Share (EPS)<0.01
Cash Flow
In the last 12 months, operating cash flow was -1.49M and capital expenditures -247.39K, giving a free cash flow of -1.73M billion.
Operating Cash Flow-1.49M
Free Cash Flow-1.73M
Free Cash Flow per Share>-0.01
Dividends & Yields
Linike Medical Group pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.74
52-Week Price Change0.00%
50-Day Moving Average0.02
200-Day Moving Average―
Relative Strength Index (RSI)12.99
Average Volume (3m)5.60K
Important Dates
Linike Medical Group upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Linike Medical Group as a current ratio of 3.99, with Debt / Equity ratio of 42.70%
Current Ratio3.99
Quick Ratio2.74
Debt to Market Cap1.17
Net Debt to EBITDA5.25
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Linike Medical Group has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Linike Medical Group EV to EBITDA ratio is 9.87, with an EV/FCF ratio of -120.89.
EV to Sales2.97
EV to EBITDA9.87
EV to Free Cash Flow-120.89
EV to Operating Cash Flow-2.07K
Balance Sheet
Linike Medical Group has $41.53K in cash and marketable securities with $16.43M in debt, giving a net cash position of -$16.39M billion.
Cash & Marketable Securities$41.53K
Total Debt$16.43M
Net Cash-$16.39M
Net Cash Per Share-$0.02
Tangible Book Value Per Share$0.06
Margins
Gross margin is 35.25%, with operating margin of 28.91%, and net profit margin of 28.91%.
Gross Margin35.25%
Operating Margin28.91%
Pretax Margin28.91%
Net Profit Margin28.91%
EBITDA Margin30.15%
EBIT Margin28.91%
Analyst Forecast
The average price target for Linike Medical Group is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―